STOCK TITAN

Polyrizon (PLRZ) furnishes June 30, 2025 interim results and MD&A on Form 6-K

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
6-K

Rhea-AI Filing Summary

Polyrizon Ltd. has submitted a Form 6-K as a foreign private issuer, furnishing its interim condensed financial statements as of June 30, 2025 and related notes. The report also includes management’s discussion and analysis of financial condition and results of operations for the six months ended June 30, 2025.

Certain exhibits to this Form 6-K are incorporated by reference into Polyrizon’s existing Form S-8 registration statements, meaning the updated financial and narrative information becomes part of those employee equity plan registrations from the submission date.

Positive

  • None.

Negative

  • None.

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

Form 6-K

 

Report of Foreign Private Issuer

Pursuant to Rule 13a-16 or 15d-16

under the Securities Exchange Act of 1934

 

For the month of September 2025

 

Commission file number: 001-42375

 

Polyrizon Ltd.

(Translation of registrant’s name into English)

 

5 Ha-Tidhar Street

Raanana, 4366507, Israel

(Address of principal executive offices)

 

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.

 

Form 20-F         Form 40-F 

 

 

 

 

 

 

CONTENTS

 

This Report of Foreign Private Issuer on Form 6-K consists of (i) the Registrant’s Interim Condensed Financial Statements as of June 30, 2025, which is attached hereto as Exhibit 99.1; and (ii) the Registrant’s Management’s Discussion and Analysis of Financial Condition and Results of Operations for the six months ended June 30, 2025, which is attached hereto as Exhibit 99.2.

 

Exhibit 99.2, Exhibit 99.3 attached to this Form 6-K are incorporated by reference into the Registrant’s Registration Statements on Form S-8 (File No. 333-284410 and 333-288923), filed with the Securities and Exchange Commission, to be a part thereof from the date on which this report is submitted, to the extent not superseded by documents or reports subsequently filed or furnished.

 

1

 

 

EXHIBIT INDEX

 

Exhibit No.    
99.1   Polyrizon Ltd.’s Interim Condensed Financial Statements as of June 30, 2025.
99.2   Polyrizon Ltd.’s Management’s Discussion and Analysis of Financial Condition and Results of Operations for the six months ended June 30, 2025.
101.INS   Inline XBRL Instance Document
101.SCH   Inline XBRL Taxonomy Extension Schema Document
101.CAL   Inline XBRL Taxonomy Extension Calculation Linkbase Document
101.LAB   Inline XBRL Taxonomy Extension Label Linkbase Document
101.PRE   Inline XBRL Taxonomy Extension Presentation Linkbase Document
101.DEF   Inline XBRL Taxonomy Extension Definition Linkbase Document
104   Cover Page Interactive Data File formatted as Inline XBRL and contained in Exhibit 101

 

2

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

  Polyrizon Ltd.
   
Date: September 17, 2025 By: /s/ Tomer Izraeli
  Name:  Tomer Izraeli
  Title: Chief Executive Officer

 

3

 

FAQ

What does Polyrizon Ltd. (PLRZ) disclose in this Form 6-K?

Polyrizon Ltd. furnishes its interim condensed financial statements as of June 30, 2025 and management’s discussion and analysis for the six months ended June 30, 2025, providing updated financial and operating information to investors.

Which financial period is covered by Polyrizon (PLRZ) in this 6-K filing?

The filing covers interim condensed financial statements as of June 30, 2025 and management’s discussion and analysis for the six-month period ended June 30, 2025, offering a mid-year view of Polyrizon’s financial condition and results.

How is this Polyrizon (PLRZ) Form 6-K used in existing registration statements?

Exhibits to this Form 6-K are incorporated by reference into Polyrizon’s Form S-8 registration statements, so the interim financial statements and MD&A become part of those equity compensation registrations from the submission date, updating supporting disclosure.

What exhibits are attached to Polyrizon Ltd.’s (PLRZ) September 2025 Form 6-K?

Attached exhibits include interim condensed financial statements as of June 30, 2025, management’s discussion and analysis for the six months then ended, and related Inline XBRL files, such as instance, schema, calculation, label, presentation, and definition documents.

Who signed the September 2025 Polyrizon (PLRZ) Form 6-K submission?

The Form 6-K was signed on behalf of Polyrizon Ltd. by Chief Executive Officer Tomer Izraeli, indicating authorized company approval of the interim financial and narrative information furnished in the report.
Polyrizon Ltd

NASDAQ:PLRZ

View PLRZ Stock Overview

PLRZ Rankings

PLRZ Latest News

PLRZ Latest SEC Filings

PLRZ Stock Data

18.95M
1.61M
Biotechnology
Healthcare
Link
Israel
Ra'anana